Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Sutro Biopharma (STRO) Tax Provisions (2022 - 2025)

Historic Tax Provisions for Sutro Biopharma (STRO) over the last 4 years, with Q2 2025 value amounting to -$18000.0.

  • Sutro Biopharma's Tax Provisions fell 32500.0% to -$18000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 8655.87%. This contributed to the annual value of $2.4 million for FY2024, which is 8681.32% down from last year.
  • Sutro Biopharma's Tax Provisions amounted to -$18000.0 in Q2 2025, which was down 32500.0% from $2.4 million recorded in Q4 2024.
  • Over the past 5 years, Sutro Biopharma's Tax Provisions peaked at $15.8 million during Q4 2023, and registered a low of -$18000.0 during Q2 2025.
  • Its 4-year average for Tax Provisions is $2.9 million, with a median of $1.1 million in 2023.
  • In the last 5 years, Sutro Biopharma's Tax Provisions crashed by 8487.51% in 2024 and then crashed by 32500.0% in 2025.
  • Over the past 4 years, Sutro Biopharma's Tax Provisions (Quarter) stood at $2.5 million in 2022, then soared by 532.6% to $15.8 million in 2023, then crashed by 84.88% to $2.4 million in 2024, then crashed by 100.75% to -$18000.0 in 2025.
  • Its Tax Provisions was -$18000.0 in Q2 2025, compared to $2.4 million in Q4 2024 and $8000.0 in Q2 2024.